Cox regression analysis further revealed that high pre-treatment PIKFYVE expression was associated with poorer clinical outcome (P = 0.01) independently of age, sex, race, and cancer type (SI Appendix, Fig. S5C). This evidence concerns the gene PIKFYVE and cancer.